Press release
Treatment-Resistant Depression Market is Expected to Witness Significant Growth by 2036 Due to Rising Disease Burden and Advancements in Novel Psychedelic-Based Therapies | DelveInsight
DelveInsight, a leading market research firm, announces the release of its latest report, "DelveInsight's Treatment-Resistant Depression (TRD) Market Insights, Epidemiology, and Market Forecast 2036." This comprehensive report provides an in-depth understanding of TRD, including historical and forecasted epidemiology, market trends, and treatment scenarios across the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.
Key Takeaways from the Treatment-Resistant Depression (TRD) Market
*
The total market size of TRD in the 7MM was approximately USD 3,726 million in 2022 and is projected to reach nearly USD 5,874 million by 2036.
*
As per DelveInsight analysis, there were approximately 6.6 million prevalent cases of TRD across the 7MM in 2025, and this figure is projected to rise by 2036.
*
The United States accounted for nearly 71% of the patient share of TRD cases in the 7MM in 2025.
*
In 2025, an estimated 1.2 million males and 3.4 million females in the US were affected by TRD, indicating higher prevalence among females.
*
Germany reported the highest number of TRD cases among the EU4 and the UK in 2025, with approximately 600,000 prevalent cases.
*
Italy had the lowest prevalent population of TRD in 2025, with approximately 140 thousand cases.
*
The TRD treatment pipeline includes emerging therapies such as COMP360 by COMPASS Pathways, BPL-003 by Atai Beckley, and VLS-01 by Atai Beckley.
*
In January 2025, Johnson & Johnson announced that SPRAVATO (esketamine) received approval in the US as the first and only monotherapy specifically indicated for adults with TRD.
Keen to know more about the market? Request our sample page athttps://www.delveinsight.com/sample-request/treatment-resistant-depression-trd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=kspr
Key Factors Driving the Treatment-Resistant Depression Market
Increasing Burden of Depression and Treatment Resistance:A growing number of patients fail to respond adequately to conventional antidepressants despite appropriate treatment duration and dosage, significantly increasing the burden of TRD globally.
Advancements in Psychedelic-Based Therapies:The emergence of novel psychedelic-based therapies such as psilocybin and DMT-derived treatments is expected to transform the TRD treatment landscape by offering rapid and durable antidepressant effects.
Growing Adoption of Innovative Therapies:The increasing acceptance and clinical adoption of therapies such as SPRAVATO, transcranial magnetic stimulation (TMS), and other neuromodulation approaches are improving treatment outcomes in TRD patients.
Rising Awareness Regarding Mental Health Disorders:Improved awareness campaigns, expanded mental healthcare access, and growing recognition of depression-related disabilities are contributing to earlier diagnosis and better treatment access.
Treatment-Resistant Depression Competitive Landscape
*
Several companies are actively working to strengthen the TRD pipeline through innovative treatment approaches. Key companies involved in the TRD market include COMPASS Pathways, Atai Beckley, Johnson & Johnson, and others.
*
Promising therapies such as COMP360, BPL-003, and VLS-01 are currently being evaluated in clinical studies for their potential to deliver rapid antidepressant responses with durable efficacy.
Discover more about therapies set to grab major Treatment-Resistant Depression market share @ Treatment-Resistant Depression Treatment Landscape [https://www.delveinsight.com/sample-request/treatment-resistant-depression-trd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=kspr]
Recent Developments in the Treatment-Resistant Depression Market
*
In May 2026, COMPASS Pathways announced that the Phase III COMP006 trial of COMP360 psilocybin in TRD met its primary endpoint, demonstrating statistically significant and clinically meaningful reductions in MADRS scores at Week 6.
*
In March 2026, Atai Beckley reported key clinical and regulatory updates for BPL-003 and announced plans to initiate Phase III development in Q2 2026 following a successful End-of-Phase II meeting with the FDA.
*
In November 2025, Atai Beckley reported positive Phase IIb open-label extension data for BPL-003, with the 12 mg dose showing sustained antidepressant effects for up to two months.
*
In January 2026, Johnson & Johnson presented new post-hoc Phase III analyses evaluating the effects of SPRAVATO on anhedonia in adults with TRD at the American College of Neuropsychopharmacology Annual Meeting.
*
In November 2025, Atai Beckley announced the successful completion of the strategic combination between atai Life Sciences and Beckley Psytech focused on psychedelic-based neuroplastogens for mental health disorders.
What is Treatment-Resistant Depression (TRD)?
Treatment-Resistant Depression generally refers to a condition in which individuals do not respond adequately to at least one course of antidepressant therapy administered at appropriate doses and duration.
TRD is influenced by biological, psychological, and environmental factors including genetic predisposition, neurotransmitter imbalances, chronic stress, trauma, socioeconomic challenges, family conflicts, and comorbid conditions.
Current treatment approaches for TRD include pharmacological strategies such as switching or augmenting antidepressants, along with non-pharmacological treatments including electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), vagus nerve stimulation (VNS), and cognitive behavioral therapy (CBT).
Treatment-Resistant Depression Epidemiology Segmentation
The Treatment-Resistant Depression epidemiology section provides insights into the historical and current TRD patient pool and forecasted trends for the leading markets. The TRD market report proffers epidemiological analysis for the study period 2022-2036 in the 7MM segmented into:
*
Total Prevalent Cases of TRD
*
Gender-specific Prevalent Cases of TRD
*
Age-specific Prevalent Cases of TRD
*
Diagnosed Prevalent Cases of MDD
*
Treatment Eligible Population
*
Treated Cases of MDD
Scope of the Treatment-Resistant Depression Market Report
*
Therapeutic Assessment: TRD current marketed and emerging therapies
*
TRD Market Dynamics: Key Market Forecast Assumptions and Market Outlook
*
Key Companies: COMPASS Pathways, Atai Beckley, Johnson & Johnson, and others
*
Key Therapies: SPRAVATO, COMP360, BPL-003, VLS-01, and others
*
Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
*
Unmet Needs, KOL's views, Analyst's views, TRD Market Access and Reimbursement
To know more about Treatment-Resistant Depression companies working in the treatment market, visit @ Treatment-Resistant Depression Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/treatment-resistant-depression-trd-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=kspr]
Table of Contents
*
Treatment-Resistant Depression Market Report Introduction
*
Executive Summary for TRD
*
SWOT Analysis of TRD
*
TRD Patient Share (%) Overview at a Glance
*
TRD Market Overview at a Glance
*
TRD Disease Background and Overview
*
TRD Epidemiology and Patient Population
*
Country-Specific Patient Population of TRD
*
TRD Current Treatment and Medical Practices
*
TRD Unmet Needs
*
TRD Emerging Therapies
*
TRD Market Outlook
*
Country-Wise TRD Market Analysis (2022-2036)
*
TRD Market Access and Reimbursement of Therapies
*
TRD Market Drivers
*
TRD Market Barriers
*
TRD Appendix
*
TRD Report Methodology
*
DelveInsight Capabilities
*
Disclaimer
*
About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kirti Sharma
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=treatmentresistant-depression-market-is-expected-to-witness-significant-growth-by-2036-due-to-rising-disease-burden-and-advancements-in-novel-psychedelicbased-therapies-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: https://www.delveinsight.com/consulting/due-diligence-services
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Treatment-Resistant Depression Market is Expected to Witness Significant Growth by 2036 Due to Rising Disease Burden and Advancements in Novel Psychedelic-Based Therapies | DelveInsight here
News-ID: 4534338 • Views: …
More Releases from ABNewswire
How to Choose a Garden Tool Set for Export Quality Standards
Why the Right Garden Tool Set Matters
The global horticultural equipment market demands high-performance hand tools, making the procurement of a reliable garden tool set a critical strategic decision for importers, wholesalers, and large-scale distributors. Selecting tools that meet strict export quality standards ensures product longevity, protects brand reputation in competitive retail landscapes, and guarantees compliance with stringent regional regulations. A meticulously sourced tool set minimizes downstream liabilities and maximizes retail…
Why Choose Membrane Disc Diffuser for Efficient Aeration?
When you're trying to find the best way to get some efficient aeration going, picking the right technology really makes all the difference. You might have heard about the Membrane Disc Diffuser [https://www.juntaienviro.com/membrane-disc-diffuser/]- it's become pretty popular in wastewater Treatment Plants [https://www.juntaienviro.com/treatment-plants/] these days, mainly because it performs so well. According to a report from the EPA, aeration can actually eat up to 60% of the energy costs in these…
Global Eosinophilic Esophagitis (EoE) Market to Witness Significant Growth Throu …
DelveInsight's "Eosinophilic Esophagitis (EoE) Market Insights, Epidemiology, and Market Forecast-2030" report provides a comprehensive analysis of the disease landscape, epidemiology trends, current treatment practices, emerging therapies, market dynamics, and competitive intelligence across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
The global Eosinophilic Esophagitis (EoE) market is expected to experience substantial growth during the forecast period 2018-2030, fueled by increasing disease awareness, advancements in diagnostic…
Why is Surface Cleaning Essential for Global Supply Chains?
In today's super-connected world, the efficiency of global supply chains really depends on a bunch of different factors. One thing that's often overlooked but super important is Surface Cleaning [https://www.8waterhk.com/surface-cleaning/]. According to Dr. Jane Smith from CleanTech Solutions, it's not just about making things look shiny-"Surface Cleaning [https://www.8waterhk.com/surface-cleaning/] is about keeping products safe and intact all along the supply chain." Makes sense, right? It's a key piece of the puzzle…
More Releases for TRD
TRD-Point and How Online Reputation Is Built in Real Time in Modern Finance
The way online reputation is formed has changed fundamentally in recent years. Instead of being shaped over long periods through static branding and delayed feedback, reputation in digital finance is now built in real time-continuously influenced by user interaction, platform updates, and evolving expectations. This shift is redefining how companies are perceived and how trust is established.
In the past, reputation was largely driven by controlled signals: official messaging, polished website…
United States Treatment-Resistant Depression (TRD) Market Boom | Top Companies, …
DataM Intelligence has released an in-depth research report on "Treatment-Resistant Depression Market Size 2025". This report delivers power-packed insights into key growth drivers, market segmentation, regional trends, CAGR forecasts, revenue performance of top players, and emerging opportunities. Gain a 360° market perspective with detailed analysis on value, volume, and future development trends your ultimate guide to spotting high-impact opportunities and staying ahead in this dynamic market.
Mergers & Acquisitions
The TRD market…
Treatment-Resistant Depression (TRD) Market Growth, Trends, Consumer Demand and …
Introduction
Depression is one of the most common mental health disorders worldwide. While many patients respond positively to first-line antidepressant therapies, a significant proportion fail to achieve remission even after multiple treatment attempts. This subgroup is diagnosed with treatment-resistant depression (TRD), a severe and disabling condition that increases the risk of hospitalization, suicide, and chronic functional impairment.
With growing global recognition of mental health as a public health priority, there is an…
Autosculpt Market Next Big Move | Major Giants ABT, Shelby, TRD, BMW, Benz
The latest report released on Autosculpt Market - Global Outlook and Forecast Market analyses areas where there is still room for improvement. Irrespective of industry, organization size, or geographic location, the Autosculpt Market - Outlook and Forecast Market study suggests that advanced technologies are playing a bigger role than ever before. The market Study is segmented by key a region that is accelerating the marketization. The assessment provides trends, growth…
Treatment-resistant Depression (TRD) Market Global Research and Clinical Survey …
“The Treatment-resistant Depression (TRD) Market Research Report” examines the existing as well as sequential performance of the worldwide market. The report also calculates the forthcoming status of Treatment-resistant Depression (TRD) market based on thorough analysis. By providing exploratory techniques such as, qualitative and quantitative analysis the report presents a comprehensive analysis of market progression. The report provides Graphical presentation of information through charts, (graphs, diagrams as well as pictures) and…
Global Handheld Gimbal Market : Feiyu, Freefly, DJI Tech, Wondlan, Rollei, TRD F …
Handheld Gimbal is a pivoted support that cooperates with the light photographic equipment, such as mainstream sports cameras, mobile phones, micro single which lets the consumer get more stable video material in the movement, and handheld gimbal itself is small, portable, easy operation, etc..
Get a Sample of Handheld Gimbal Market research report from @ http://www.globalinforeports.com/request-sample/247721
Scope of the Report:
This report focuses on the Handheld Gimbal…
